4
Changes in Ownership
RenovoRx, Inc. Filed Acc 0001493152-26-015592
Options or other derivatives
- Chief Clinical Officer acquired 128,550 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Gentry Leesa Chief Clinical Officer | 2026-04-03 | Grant or award · Stock Option | +128,550 | 128,550 | D | ||
Loading xslF345X06/ownership.xml…